These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23492819)

  • 1. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
    Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
    Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
    Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
    Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-153 Regulates NRF2 Expression and is Associated with Breast Carcinogenesis.
    Wang B; Teng Y; Liu Q
    Clin Lab; 2016; 62(1-2):39-47. PubMed ID: 27012032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
    Munagala R; Aqil F; Vadhanam MV; Gupta RC
    Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
    Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
    BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.
    Singh B; Bhat HK
    Carcinogenesis; 2012 Dec; 33(12):2601-10. PubMed ID: 23027624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
    Singh B; Bhat NK; Bhat HK
    Carcinogenesis; 2012 Jan; 33(1):156-63. PubMed ID: 22072621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.
    Mahajan M; Sitasawad S
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
    Mense SM; Singh B; Remotti F; Liu X; Bhat HK
    Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.
    Smolarek AK; So JY; Thomas PE; Lee HJ; Paul S; Dombrowski A; Wang CX; Saw CL; Khor TO; Kong AN; Reuhl K; Lee MJ; Yang CS; Suh N
    Mol Carcinog; 2013 Jul; 52(7):514-25. PubMed ID: 22389237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 regulates arsenite-induced malignant transformation by targeting Nrf2-mediated oxidative damage in human bronchial epithelial cells.
    Chen C; Jiang X; Gu S; Zhang Z
    Toxicol Lett; 2017 Aug; 278():38-47. PubMed ID: 28688901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
    Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
    Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.
    Park SA; Lee MH; Na HK; Surh YJ
    Oncotarget; 2017 Jan; 8(1):164-178. PubMed ID: 27438141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
    Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
    J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
    Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
    J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
    Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
    Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic potential of fluorinated estrogens in mammary tumorigenesis.
    Okamoto Y; Jinno H; Itoh S; Shibutani S
    Toxicol Lett; 2020 Jan; 318():99-103. PubMed ID: 31669098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
    Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
    Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells.
    Son YO; Pratheeshkumar P; Divya SP; Zhang Z; Shi X
    J Biol Chem; 2017 May; 292(20):8315-8330. PubMed ID: 28330870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells.
    Chen Y; Wang J; Hong DY; Chen L; Zhang YY; Xu YN; Pan D; Fu LY; Tao L; Luo H; Shen XC
    Oncotarget; 2017 Feb; 8(6):10470-10484. PubMed ID: 28060756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.